Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 2
Encontrada(s) 1 página(s)

RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Functional Signatures in Non-Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis of Sex-Based Differences in Transcriptomic Studies

  • Pérez-Díez, Irene
  • Hidalgo, Marta R.
  • Malmierca-Merlo, Pablo
  • Andreu, Zoraida
  • Romera-Giner, Sergio
  • Farràs, Rosa
  • Provencio, Mariano
  • Romero, Atocha
  • García-García, Francisco
  • DE LA IGLESIA VAYÁ, MARIA DE LOS DESAMPARADOS
[EN] While studies have established the existence of differences in the epidemiological and clinical patterns of lung adenocarcinoma between male and female patients, we know relatively little regarding the molecular mechanisms underlying such sex-based differences. In this study, we explore said differences through a meta-analysis of transcriptomic data. We performed a meta-analysis of the functional profiling of nine public datasets that included 1366 samples from Gene Expression Omnibus and The Cancer Genome Atlas databases. Meta-analysis results from data merged, normalized, and corrected for batch effect show an enrichment for Gene Ontology terms and Kyoto Encyclopedia of Genes and Genomes pathways related to the immune response, nucleic acid metabolism, and purinergic signaling. We discovered the overrepresentation of terms associated with the immune response, particularly with the acute inflammatory response, and purinergic signaling in female lung adenocarcinoma patients, which could influence reported clinical differences. Further evaluations of the identified differential biological processes and pathways could lead to the discovery of new biomarkers and therapeutic targets. Our findings also emphasize the relevance of sex-specific analyses in biomedicine, which represents a crucial aspect influencing biological variability in disease., This work was supported by Fondo de Investigación Sanitaria (ISCIII PI15-00209), GV/2020/186, and ISCIII PT17/0009/0015 FEDER.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Lung tumorspheres reveal cancer stem cell-like properties and a score with prognostic impact in resected non-small cell lung cancer

  • Herreros-Pomares, Alejandro|||0000-0003-3838-097X
  • Sirera Pérez, Rafael|||0000-0001-9162-8490
  • Jantus-Lewintre, Eloisa|||0000-0001-7395-4380
  • de Maya-Gironés, J.D.
  • Calabuig-Fariñas, Silvia
  • Lucas, Rut
  • Martínez-Romero, Alicia
  • Pardo-Sánchez, José Miguel
  • Alonso, Sergio
  • Blasco-Cordellat, Ana
  • Guijarro, Ricardo
  • Martorell, Miguel
  • Escorihuela, Eva
  • Chiara, María Dolores
  • Durendez-Saez, Elena
  • Gandía, Carolina
  • Forteza, Jerónimo
  • Farràs, Rosa
  • Camps-Herrero, Carlos
[EN] The high resistance against current therapies found in non-small-cell lung cancer (NSCLC) has been associated to cancer stem-like cells (CSCs), a population for which the identification of targets and biomarkers is still under development. In this study, primary cultures from early-stage NSCLC patients were established, using sphere-forming assays for CSC enrichment and adherent conditions for the control counterparts. Patient-derived tumorspheres showed self-renewal and unlimited exponential growth potentials, resistance against chemotherapeutic agents, invasion and differentiation capacities in vitro, and superior tumorigenic potential in vivo. Using quantitative PCR, gene expression profiles were analyzed and NANOG, NOTCH3, CD44, CDKN1A, SNAI1, and ITGA6 were selected to distinguish tumorspheres from adherent cells. Immunoblot and immunofluorescence analyses confirmed that proteins encoded by these genes were consistently increased in tumorspheres from adenocarcinoma patients and showed differential localization and expression patterns. The prognostic role of genes significantly overexpressed in tumorspheres was evaluated in a NSCLC cohort (N = 661) from The Cancer Genome Atlas. Based on a Cox regression analysis, CDKN1A, SNAI1, and ITGA6 were found to be associated with prognosis and used to calculate a gene expression score, named CSC score. Kaplan¿Meier survival analysis showed that patients with high CSC score have shorter overall survival (OS) in the entire cohort [37.7 vs. 60.4 months (mo), p = 0.001] and the adenocarcinoma subcohort [36.6 vs. 53.5 mo, p = 0.003], but not in the squamous cell carcinoma one. Multivariate analysis indicated that this gene expression score is an independent biomarker of prognosis for OS in both the entire cohort [hazard ratio (HR): 1.498; 95% confidence interval (CI), 1.167¿1.922; p = 0.001] and the adenocarcinoma subcohort [HR: 1.869; 95% CI, 1.275¿2.738; p = 0.001]. This score was also analyzed in an independent cohort of 114 adenocarcinoma patients, confirming its prognostic value [42.90 vs. not reached (NR) mo, p = 0.020]. In conclusion, our findings provide relevant prognostic information for lung adenocarcinoma patients and the basis for developing novel therapies. Further studies are required to identify suitable markers and targets for lung squamous cell carcinoma patients., This work was supported by Fondo de Investigación Sanitaria, ISCIII (PI12-02838, PI12-00956, PI15-00753, PI15-00209), and Fundación Arnal Planelles. A. H.-P. and J.M.P.-S. are supported by Ministerio de Educación, Cultura y Deporte (FPU14/06911 and FPU13/02755, respectively).